Skip to main content

Table 1 Mean (+/- SD) serum lipids and e-GFR.

From: The TOKEN study: safety and efficacy of Truvada or Kivexa in combination with efavirenz in treatment-naïve predominantly black African HIV patients

  

TC mmol/l

TG mmol/l

HDL mmol/l

TC/HDL

e-GFR ml/min

Truvada

Baseline

4.0 (0.9)

1.3 (0.8)

1.2 (0.4)

3.6 (1.9)

104.7 (24.0)

 

48 weeks

4.2 (0.9)

1.3 (0.9)

1.5 (0.5)

3.3 (1.1)

108.3 (36.5)

Kivexa

Baseline

4.4 (0.8)

1.5 (1.0)

1.1 (0.3)

3.8 (1.1)

104.8 (30.0)

 

48 weeks

5.0 (1.0)

1.5 (1.0)

1.7 (0.8)

3.3 (1.2)

117.3 (31.7)

p-values

 

0.04

0.7

0.7

0.3

0.1